NCT04796220View on ClinicalTrials.gov

Focused Ultrasound and Gemcitabine in Breast Cancer

PHASE1RecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

January 27, 2022

Primary Completion Date

September 30, 2029

Study Completion Date

February 28, 2030

Conditions
Breast CancerBreast Neoplasms
Interventions
DEVICE

Focused Ultrasound

Focused ultrasound will be applied to up to 2 breast lesions on day 8.

OTHER

Gemcitabine and Focused Ultrasound

Gemcitabine (900 mg/m2) will be administered intravenously on day 1.Focused ultrasound will be applied to up to 2 breast lesions on day 8.

Trial Locations (1)

22903

RECRUITING

University of Virginia, Charlottesville

All Listed Sponsors
lead

Patrick Dillon, MD

OTHER